Key result
Adding arterial pressure variability to clinical predictors improves 48-hour EEG outcome prediction in HIE infants.
Why the study?
The study aimed to evaluate arterial blood pressure variability as an objective physiologic biomarker for early identification of adverse short-term EEG outcomes in infants with hypoxic-ischemic encephalopathy.
Does adding early time- and frequency-domain mean arterial blood pressure variability metrics to perinatal clinical predictors improve the prediction of abnormal 48-hour EEG background in infants with hypoxic-ischemic encephalopathy?
Cohort (n=91)
Yes
Does adding early time- and frequency-domain mean arterial blood pressure variability metrics to perinatal clinical predictors improve the prediction of abnormal 48-hour EEG background in infants with hypoxic-ischemic encephalopathy?
Early time- and frequency-domain arterial blood pressure variability metrics measured at 21-24 hours of life substantially improve the prediction of 48-hour adverse EEG outcomes over standard perinatal clinical variables in neonates with hypoxic-ischemic encephalopathy.
OBJECTIVE: This study aimed to evaluate the role of an objective physiologic biomarker, arterial blood pressure variability, for the early identification of adverse short-term electroencephalogram (EEG) outcomes in infants with hypoxic-ischemic encephalopathy (HIE). STUDY DESIGN: In this multicenter observational study, we analyzed blood pressure of infants meeting these criteria: (1) neonatal encephalopathy determined by modified Sarnat exam, (2) continuous mean arterial blood pressure (MABP) data between 18 and 27 hours after birth, and (3) continuous EEG performed for at least 48 hours. Adverse outcome was defined as moderate-severe grade EEG at 48 hours. Standardized signal preprocessing was used; the power spectral density was computed without interpolation. Multivariate binary logistic regression was used to identify which MABP time and frequency domain metrics provided improved predictive power for adverse outcomes compared with standard clinical predictors (5-minute Apgar score and cord pH) using receiver operator characteristic analysis. RESULTS: Ninety-one infants met inclusion criteria. The mean gestational age was 38.4 ± 1.8 weeks, the mean birth weight was 3,260 ± 591 g, 52/91 (57%) of infants were males, the mean cord pH was 6.95 ± 0.21, and 10/91 (11%) of infants died. At 48 hours, 58% of infants had normal or mildly abnormal EEG background and 42% had moderate or severe EEG backgrounds. Clinical predictor variables (10-minute Apgar score, Sarnat stage, and cord pH) were modestly predictive of 48 hours EEG outcome with area under curve (AUC) of 0.66 to 0.68. A composite model of clinical and optimal time- and frequency-domain blood pressure variability had a substantially improved AUC of 0.86. CONCLUSION: Time- and frequency-domain blood pressure variability biomarkers offer a substantial improvement in prediction of later adverse EEG outcomes over perinatal clinical variables in a two-center cohort of infants with HIE. KEY POINTS: · Early outcome prediction in HIE is suboptimal.. · Patterns in blood pressure physiology may be predictive of short-term outcomes.. · Early time- and frequency-domain measures of blood pressure variability predict short-term EEG outcomes in HIE infants better than perinatal factors alone..
No takes yet. Share an insight, caveat, or question.
Flower et al. (2020) conducted a cohort in Hypoxic-ischemic encephalopathy (HIE) (n=91). Composite model of clinical predictors and time- and frequency-domain mean arterial blood pressure (MABP) variability metrics (21-24 hours after birth) vs. Perinatal clinical predictor variables alone (5-minute or 10-minute Apgar score, Sarnat stage, and arterial cord pH) was evaluated on Moderate-to-severe grade abnormal electroencephalogram (EEG) background pattern or electrographically confirmed seizures at 48 hours (AUC 0.86 vs AUC 0.66-0.68). Time- and frequency-domain mean arterial blood pressure variability combined with clinical predictors improved prediction of 48-hour adverse EEG outcomes in HIE infants (AUC 0.86 vs 0.66-0.68).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: